A Hopeful and Systematic Path with a New Therapy for Parkinson’s Disease

A Hopeful and Systematic Path with a New Therapy for Parkinson’s Disease

Mohammadesmail Nikfar1

1) Associate Professor, Ph.D. in Mathematics, Department of Mathematics, School of Hekmat 1, District 4, Tehran, Iran.

IOI Code : AEZG-ACAEAE
Publication : The 12th National Conference on Interdisciplinary Research in Management and Medical Sciences, Tehran(https://ircmms.ir/12th)
Abstract :
    Given the long-standing lack of success with traditional treatments for Parkinson’s disease, there is a clear, unmet need for the development of novel therapies aimed at alleviating debilitating symptoms and halting disease progression. This article provides a critical, up-to-date review of some of the most promising emerging treatments—including gene therapy, cell-based therapies, targeted drug delivery, and neuroprotective agents—while examining the associated challenges, limitations, and future research directions. Gene therapy for Parkinson’s, particularly approaches utilizing AAV (adeno-associated virus) vectors to target neurotrophic factors, dopamine production, and neural circuits, has shown promise in both animal and clinical studies. In the realm of targeted drug delivery, nanotechnology has emerged as a promising avenue; it enables the creation of drug-delivery vehicles capable of crossing the blood-brain barrier to transport therapeutic agents specifically to the brain regions affected by Parkinson’s. Neuroprotective agents—compounds capable of shielding neurons from degeneration and death—hold significant potential for the development of disease-modifying therapies. Furthermore, magnetic field therapy has shown promise as a non-invasive method for enhancing neuroplasticity. Key challenges for future research into these novel Parkinson’s treatments include the establishment of standardized protocols for animal and human studies, as well as addressing concerns regarding safety, ethical considerations, and cost-effectiveness. The development of novel and emerging therapies has pointed toward a promising path for effective, personalized, and curative treatments.

Keywords : parkinson's disease gene therapy cell based and magnetic field based therapies targeted drug delivery neuroprotective agents